Omecamtiv Mecarbil - Improves Survival in Heart Failure Patients

GALACTIC-HF multicentre trial showed that omecamtiv mecarbil was superior to placebo at improving cardiovascular outcomes in heart failure patients with low ejection fraction

from Medindia Health News https://ift.tt/2UWyqXm